New insights into adolescent acne

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 6, 2009, Pages 645-661

  Elsaie, M L ^a,b,d   Choudhary, S ^a   Kammer, J N ^a,c  

^a UNIVERSITY OF MIAMI   (United States)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acne vulgaris; Benzoyl peroxide; Botulinum toxin type A; Diet; Lasers; Retinoids

Indexed keywords

ACZONE; ADAPALENE; ANTIBIOTIC AGENT; BACTERIAL VACCINE; BENZOYL PEROXIDE; BOTULINUM TOXIN A; CATECHIN; CLINDAMYCIN PHOSPHATE; CORYNEBACTERIUM ACNES VACCINE; CYPROTERONE ACETATE; DAPSONE; DIENOGEST; DROSPIRENONE PLUS ETHINYLESTRADIOL; EPIGALLOCATECHIN GALLATE; ETHINYLESTRADIOL; INDOCYANINE GREEN; ISOTRETINOIN; MATRIX METALLOPROTEINASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; RETINOID; SALICYLIC ACID; TAZAROTENE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; ZINERYT;

ACNE VULGARIS; ANTIBIOTIC THERAPY; BIOFILM; CACAO; DAIRY PRODUCT; DIET; DIODE LASER; DRUG EFFICACY; DRUG TOLERABILITY; EXERCISE; FAT INTAKE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLYCEMIC INDEX; HEMOLYTIC ANEMIA; HUMAN; HYGIENE; LOW LEVEL LASER THERAPY; MONOTHERAPY; MORBIDITY; MORTALITY; MOUSE; NEUROSIS; NONHUMAN; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTOGRAPHY; PROPIONIBACTERIUM ACNES; PULSED DYE LASER; REVIEW; SCORING SYSTEM; SEBACEOUS GLAND; SELF ESTEEM; SWEATING; TEA; TOPICAL TREATMENT;

EID: 77949625486     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (143)

1. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: Need for policies to modify antibiotic usage. BMJ 1993;306:555-6.
2. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 2004;291:827-83.
3. Webster GF. The pathophysiology of acne. Cutis 2005;76:4-7.
4. Bergfeld WF. The pathophysiology of acne vulgaris in children and adolescents, Part 1. Cutis 2004;74:92-7.
5. Wynnis TL, Barrio VR. New insights into adolescent acne. Curr Opin Pediatr 2008;20:436-40.
6. Nakatsuji T, Liu YT, Huang CP, Zouboulis CC, Gallo RL, Huang CM. Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS One 2008;3:e1551.
7. Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003;121:20-7.
8. O'Halloran G, Miller C, Britt H. Defining chronic conditions for primary care with ICPC-2. Fam Pract 2004;21:381-6.
9. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 2005;166:1691-9.
10. Czernielewski J, Michel S, Bouclier M, Baker M and Hensby JC. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol 2001;15(Suppl):5-12.
11. Liu PT, Phan J, Tang D, Kanchanapoomi M, Hall B, Krutzik SR et al. CD209(+) macrophages mediate host defense against Propionibacterium acnes. J Immunol 2008;180:4919-23.
12. Alestas, R. Ganceviciene, S. Fimmel, K. Muller-Decker, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 2006;84:75-87.
13. Adebamowo C, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008;58:787-93.
14. Adebamowo C, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA et al. Milk consumption and acne in adolescent girls. Dermatol Online J 2006;12:1.
15. Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD. High school dietary intake and teenage acne. J Am Acad Dermatol 2005;52:207-11.
16. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris:a disease of Western civilization. Arch Dermatol 2002;138:1584-90.
17. Bendiner E. Disastrous trade-off: Eskimo health for white "civilization". Hosp Pract 1974;9:156-89.
18. Steiner PE. Necropsies on Okinawans. Arch Pathol 1946;42:359-80.
19. Hartmann S, Lacorn M, Steinhart H. Natural occurrence of steroid hormones in food. Food Chem 1998;62:7-20.
20. Aizawa H, Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995;22:249-52.
21. Cara JF. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res 1994;42:49-54.
22. Smith RN, Braue A, Varigos G, Mäkeläinen H, Varigos GA. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci 2008;50:41-52
23. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients:a randomized controlled trial. Am J Clin Nutr 2007;86:107-15.
24. Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C et al. Effects of dietary intervention on IGF-1 and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 2003;57:1079-88.
25. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70(Suppl):560S-569S.
26. Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001;203:277-9.
27. James M, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71(Suppl):343S-348S.
28. Grant JD, Anderson PC. Chocolate as a cause of acne:a dissenting view. MO Med 1965;62:459-60.
29. Fulton EJ, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. J Am Med Assoc 1969;210:2071-4.
30. Orringer JS, Kang S, Hamilton T, Schumacher W, Cho S, Hammerberg C et al. Treatment of acne vulgaris with a pulsed dye laser. A randomized controlled trial. JAMA 2004;291:2834-9.
31. Seaton ED, Charakida A, Mouser PE, Grace I, Clement RM, Chu AC. Pulsed-dye laser treatment for inflammatory acne vulgaris:randomized controlled trial. Lancet 2003;362:1347-52.
32. Fries JH. Chocolate:a review of published reports of allergic and other deleterious effects, real or presumed. Annals of Allergy 1978;41:195-207.
33. Mackie BS, Mackie LE. Chocolate and acne. Aust J Dermat 1974;15:103-9.
34. Anderson PC. Foods as the cause of acne. Am Fam Phys 1971;3:102-3.
35. Kurzen H, Kari U. Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol 2004;13:27.
36. Short RW, Agredano YZ, Choi JM, Kimball AB. A single blinded, randomized pilot study to evaluate the effect of exercise-induced sweat on truncal acne. Pediatr Dermatol 2008;25:26-8.
37. Witkowski JA, Parish LC. From the ghosts of the past:Acne lesion counting. J Am Acad Dermatol 1999;40:131.
38. Cunliffe WJ, Holland DB, Jeremy A. Comedone formation:etiology, clinical presentation, and treatment. Clin Dermatol 2004;22:367-74.
39. Do TT, Zarkhin S, Orringer JS, Nemeth S, Hamilton T, Sachs D et al. Computer-assisted alignment and tracking of acne lesions indicate that most inflammatory lesions arise from comedones and de novo. J Am Acad Dermatol 2008; 58:603-8.
40. Witkowski JA, Parish LC. The assessment of acne: An evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol 2004;22:394-7.
41. Burke BM, Cunliffe WJ. The assessment of acne vulgaris:The Leeds technique. Br J Dermatol 1984;111:83-92.
42. Magin P, Adams J, Heading G, Pond D, Smith W. Psychological sequelae of acne vulgaris:results of a qualitative study. Can Fam Physician 2006;52:978-9.
43. Layton AM, Seukeran D, Cunliffe WJ. Scarred for life? Dermatology 1997;195:S15-S21.
44. Mosam A, Vawda NB, Gordhan AH, Nkwanyana N, Aboobaker J. Quality of life issues for South Africans with acne vulgaris. Clin Exp Dermatol 2005;30:6-9.
45. Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol 2008;22:1435-44.
46. Yolaç Yarpuz A, Demirci Saadet E, Erdi Sanli H, Devrimci Ozgüven H. [Social anxiety level in acne vulgaris patients and its relationship to clinical variables]. Turk Psikiyatri Derg 2008;19:29-37.
47. Law MP, Chuh AA, Lee A, Molinari N. Acne prevalence and beyond:acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol May 2009. [Epub ahead of print]
48. Magin P, Adams J, Heading G, Pond D, Smith W. Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae:results of a qualitative study. Scand J Caring Sci 2008;22:430-6.
49. Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000;39:354-7.
50. Uslu G, Sendur N, Uslu M, Savk E, Karaman G, Eskin M. Acne:prevalence, perceptions and effects on psychological health among adolescents in Aydin, Turkey. J Eur Acad Dermatol Venereol 2008;22:462-9.
51. Jemec GB, Linneberg A, Nielsen NH, Frolund L, Madsen F, Jorgensen T. Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives. Dermatology 2002;204:179-84.
52. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989:14:194-8.
53. Jowett S, Ryan T. Skin disease and handicap: an analysis of skin conditions. Soc Sci Med 1985;20:425-9.
54. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986;115:379-83.
55. Hensen G, Schiller M, Luger TA, Hensen P. [Psychosocial Issues in Outpatient Care of Acne Vulgaris.] Gesundheitswesen 2009;71: 405-13.
56. Hahm BJ, Min SU, Yoon MY, Shin YW, Kim JS, Jung JY, Suh DH. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. J Dermatol 2009;36:255-61.
57. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin:a systematic review. Semin Cutan Med Surg 2007;26:210-20.
58. Kaymak Y, Taner E, Taner Y. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol 2009;48:41-6.
59. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ et al. Management of acne:a report from Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003;49(Suppl):S1-37.
60. Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005;141:1132-6.
61. Berthelot A, Carricajo G, Aubert H, Akhavan D, Gazielly D, Lucht F. Outbreak of postoperative shoulder arthritis due to Propionibacterium acnes infection in nondebilitated patients. Infect Control Hosp Epidemiol 2006;27:987-90.
62. Bagyalakshmi R, Madhavan HN, Therese KL. Development and application of multiplex polymerase chain reaction for the etiological diagnosis of infectious endophthalmitis. J Postgrad Med 2006;52:179-82.
63. Chanet V, Romaszko JP, Rolain JM, Beytout J. Propionibacterium acnes adenitis [French]. Presse Med 2005;34:1005-6.
64. Thiboutot DM, Weiss J Bucko A, Eichenfield L, Jones T, Clark S et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study, J Am Acad Dermatol 2007;57:791-9.
65. Andres P, Pernin C, Poncet M. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants. Cutis 2008;81:278-84.
66. Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 2009 May 21. [Epub ahead of print]
67. Leyden JJ. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne. Cutis 2004;74(4 Suppl):9-15.
68. Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris:a multicenter, double-blind, vehicle-controlled study. Cutis 1999;63:349-54.
69. Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J et al. Effects of tazarotene 0.1% cream in the treatment of facial acne vulgaris:pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Clin Ther 2004;26:1865-73.
70. Thielitz A, Naser MB, Fluhr JW, Zouboulis CC, Gollnick H. Topical retinoids in acne - an evidence-based overview. J Dtsch Dermatol Ges 2008;6:1023-31.
71. Bershad S, Kranjac SG, Parente JE, Tan MH, Sherer DW, Persaud AN et al. Successful treatment of acne vulgaris using a new method:results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol 2002;138:481-9.
72. Ross CM. The treatment of acne vulgaris with dapsone. Br J Dermatol 1961;73:367-70.
73. Prendiville JS, Logan RA, Russell-Jones R. A comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne. Clin Exp Dermatol 1988;13:67-71.
74. Scheinfeld N. Aczone, a topical gel formulation of the antibacterial, anti-inflammatory dapsone for the treatment of acne. Curr Opin Investig Drugs 2009;10:474-81.
75. Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris. Arch Dermatol 2008;144:1564-70.
76. Thiboutot DM, Willmer J, Sharata H, Haider R, Garrett S. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris. Clin Pharmacokinet 2007;46:697-712.
77. Tingle MD, Mahmud R, Maggs JL, Pirmohamed M, Park BK. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man. J Pharmacol Exp Ther 1997;283:817-23.
78. Sago J, Hall RP. Dapsone. Dermatol Ther 2002;15:340-51.
79. Schmidt E, Reimer S, Kruse N, Bröcker EB, Zillikens D. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol 2001;124:157-62.
80. Booth SA, Moddy CV, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin mediated neutrophil adherence function. J Invest Dermatol 1992;98:130-40.
81. Kazmierowski JA, Ross JE, Peizner DS, Wuepper KD. Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity. J Clin Immunol 1984;4:55-64.
82. Wozel G, Lehmann B. Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes. Skin Pharmacol 1995;8:196-202.
83. Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C et al. United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 2007;56:439.e1-10.
84. Rainier S, Maloney JM, Bourcier M, Wilson D, Papp K, Siegfried E et al., Garrett S;United States/Canada Dapsone Gel Study Group. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents. Cutis. 2008 Feb;81(2):171-8.
85. Ko HC, Song M, Seo SH, Oh CK, Kwon KS, Kim MB. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients:efficacy and tolerability. J Eur Acad Dermatol Venereol 2009;23:245-50.
86. Tan HH. Antibacterial therapy for acne:a guide to selection and use of systemic agents. Am J Clin Dermatol 2003;4:307-14.
87. Fagundes DS, Fraser JM, Klauda HC. New therapy update - a unique combination formulation in the treatment of inflammatory acne. Cutis 2003;72:16-9.
88. Chalker DK, Shalita A, Smith JG Jr, Swann RW. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. Br J Dermatol 1983;9:933-6.
89. Fluhr JW, Bosch B, Gloor M, Hoffler U. In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. Zentralbl Bakteriol 1999;289:445-56.
90. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol 2007;21:311-9.
91. Dhawan SS. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. Cutis 2009;83:265-72.
92. Liao S. The medicinal action of androgens and green tea epigallocatechin gallate. Hong Kong Med J 2001;7:369-74.
93. Hiipakka RA, Liao S. Molecular mechanism of androgen action. Trends Endocrinol Metab 1998;9:317-24.
94. Burgdorf W. Acne vulgaris.Eur J Dermatol 2008;18:107-8.
95. Liang T, Liao S. Growth suppression of hamster flank organs by topical application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase. J Invest Dermatol 1997;109:152-7.
96. Lee WL, Shalita AR, Suntharalingam K, Fikrig SM. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun 1982;35:71-8.
97. Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999;20:2117-24.
98. Camouse MM, Domingo DS, Swain FR, Conrad EP, Matsui MS, Maes D et al. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol 2009;18:522-6.
99. Trompezinski S, Denis A, Schmitt D, Viac J. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha. Arch Dermatol Res 2003;295:112-6.
100. Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 2005;125:673-84.
101. Isemura M, Saeki K, Minami T, Hayakawa S, Kimura T, Shoji Y, Sazuka M. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Ann N Y Acad Sci 1999;878:629-31.
102. Brown SK, Shalita AR. Acne vulgaris. Lancet 1998;351:1871-6.
103. Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol.1995;33(2 Pt 1):247-253.
104. Vayalil PK, Elmets CA, Katiyar SK. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003;24:927-36.
105. Afaq F, Ahmad N, Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003;18:9254-64.
106. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 2001;176:110-7.
107. Bandyopadhyay D, Chatterjee TK, Dasgupta A, Lourduraja J, Dastidar SG. In vitro and in vivo antimicrobial action of tea:the commonest beverage of Asia. Biol Pharm Bull 2005;28:2125-7.
108. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007;81:519-33.
109. Bassett IB, Pannowitz DL, Bametson RS. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990;153:455-8.
110. Alexis AF, Jones VA, Stiller MJ. Potential therapeutic applications of tea in dermatology. Int J Dermatol 1999;38:735-43.
111. Elsaie ML, Abdelhamid MF, Elsaaiee LT, Emam HM. The efficacy of topical 2% green tea lotion in mild-to-moderate acne vulgaris. J Drugs Dermatol 2009;8:358-64.
112. Liu A, Yang DJ, Gerhardstein PC, Hsu S. Relapse of acne following isotretinoin treatment:a retrospective study of 405 patients. J Drugs Dermatol. 2008 Oct;7(10):963-6.
113. Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics:Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol 2007;57:722-4.
114. Khoo KC, Reik D, Colburn WA. Pharmacokinetics of isotretinoin following a single oral dose. J Clin Pharmacol 1982;22:395-402.
115. Brazzell RK, Colburn WA. Pharmacokinetics of the retinoids isotretinoin and etretinate. J Am Acad Dermatol 1982;6:643-51.
116. Grønhøj Larsen F, Jakobsen P, Grønhøj Larsen C, Heidenheim M, Held E, Nielsen-Kudsk F. The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol. Br J Dermatol. 2009 May 21. [Epub ahead of print]
117. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA, Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2009;CD004425.
118. Palombo-Kinne E, Schellschmidt I, Schumacher U, Gräser T. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate. Contraception 2009; 79:282-9.
119. Elman M, Lask G. The role of pulsed light and heat energy (LHE(TM)) in acne clearance. J Cosmet Laser Ther 2004;6:91-95.
120. Paithankar DY, Ross EV, Saleh BA, Blair MA, Graham BS. Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 200;31:106-14.
121. Friedman PM, Jin MH, Kimyai-Asadi A, Goldberg LH. Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study. Dermatol Surg 2004;30:147-51.
122. Tuchin VV, Genina EA, Bashkatov AN, Simonenko GV, Odoevskaya OD, Altshuler GB. A pilot study of ICG laser therapy of acne vulagirs:photodynamic and photothermolysis treatment. Lasers Surg Med 2003;33:296-310.
123. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115:183-92.
124. Omi T, Munavalli GS, Kawana S, Sato S. Ultrastructural evidence for thermal injury to pilosebaceous units during the treatment of acne using photopneumatic (PPX) therapy. J Cosmeti Laser Ther 2008;10:7-11.
125. Gold MH, Biron J. Efficacy of a novel combination of pneumatic energy and broadband light for the treatment of acne. J Drugs Dermatol 2008;7:639.
126. Baumann L, Elsaie M, Grunebaum L. Botulinum toxin. In: Baumann L, editor. Cosmetic dermatology: principles and practice. 2nd edition. New York: McGraw-Hill; 2009.
127. Yosipovitch G, Reis J, Tur E, Sprecher E, Yarnitsky D, Boner G et al. Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure. Br J Dermatol 1995;133:561.
128. Nakatsuji T, Rasochova L, Huang CM. Vaccine therapy for P. acnes-associated diseases. Infect Disord Drug Targets 2008;8:160-5.
129. Nakatsuji T, Liu YT, Huang CP, Zouboulis CC, Gallo RL, Huang CM. Vaccination targeting a surface sialidase of P. acnes:implication for new treatment of acne vulgaris. PLoS One 2008;3:e1551.
130. Witkowski JA, Simons HM. Objective evaluation of demethylchortetracycline hydrochloride in the treatment of acne. JAMA 1966;196:397-400.
131. Frank SB. Acne vulgaris. Springfield, IL: Thomas; 1971.
132. Plewig G, Kligman A. Acne: morphogenesis and treatment. New York: Springer-Verlag; 1975.
133. Christiansen J, Holm P, Reymann F. Treatment of acne vulgaris with the retinoic acid derivative Ro 11-1430. A controlled clinical trial against retinoic acid. Dermatologica 1976;153:172-6.
134. Michaelsson G, Juhlin L, Vahlquist A. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol 1977;57:372.
135. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch Dermatol 1979;115:571-5.
136. Allen BS, Smith JG Jr. Various parameters for grading acne vulgaris. Arch Dermatol 1982;118:23-5.
137. Samuelson JS. An accurate photographic method for grading acne:Initial use in a double-blind clinical comparison of minocycline and tetracycline. J Am Acad Dermatol 1985;12:461-7.
138. Lucchina LC, Kollias N, Phillips SB. Quantitative evaluation of noninflammatory acne with fluorescence photography. J Invest Dermatol 1994;102:560.
139. Lucky AW, Barber BL, Girman CJ, Williams J, Ratterman J, Waldstreicher J. A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol 1996;35:559-65.
140. Phillips SB, Kollias N, Gillies R, Muccini JA, Drake LA. Polarized light photography enhances visualization of inflammatory lesions of acne vulgaris. J Am Acad Dermatol 1997;37:948-52.
141. Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997;36:416-8.
142. Tutakne MA, Chari KVR. Acne, rosacea and perioral dermatitis. In: Valia RG, Valia AR, editors. IADVL Textbook and atlas of dermatology. 2nd edition. Mumbai: Bhalani publishing House; 2003. p. 689-710.
143. Hayashi N, Suh DH, Akamatsu H, Kawashima M; Acne Study Group. Evaluation of the newly established acne severity classification among Japanese and Korean dermatologists. J Dermatol 2008;35:261-3.